What does Cellectar Biosciences, Inc. do?

Jun 22 2025 06:52 PM IST
share
Share Via
Cellectar Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer treatments, with a market cap of $16.19 million and a recent net profit loss of $7 million. The company operates in the Pharmaceuticals & Biotechnology industry and has no dividend yield.
Overview:
Cellectar Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company. Financial Snapshot: Most recent Net Profit: -7 Million (Quarterly Results - Mar 2025) Market cap: USD 16.19 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.43 Return on Equity: -549.62% Price to Book: 1.68 Contact Details: Address: 100 Campus Dr, FLORHAM PARK NJ: 07932-1020 Tel: 1 608 4418120 Fax: 1 608 4418121 Website: http://cellectar.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Cellectar Biosciences, Inc.?
Jun 22 2025 06:07 PM IST
share
Share Via